Trending News Today: Gilead HCV Drug Patents Challenged

Specialty Pharmacy Times

Gilead’s Lucrative Hep C Patents Face PTAB Assault

Law360

Gilead faces challenge to U.S. hepatitis C patents from advocacy group

STAT

Consumer group challenges Gilead patents on hepatitis C drug

Reuters

Gilead’s Patents on Hepatitis C Drug Challenged by Consumer Group

Bloomberg

Health Group Challenges Gilead Patents In The US On Grounds Of Lack Of Novelty

Intellectual Property Watch

First-Ever U.S. Patent Challenges Dispute Gilead’s Monopoly on Hepatitis C Drugs that Blocks Millions from Treatment

After India, I-MAK files legal challenge against Gilead’s hepatitis C drug sofosbuvir in China

PharmaBiz

India Rejects Gilead’s Tenofovir Patent Applications

Learn more about how you can help build a more equitable system for all